Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Feb 16, 2018 29.65 +0.17   
 Value Line VALU Feb 16, 2018 18.68 +0.05   
 Vanda Pharmaceuticals Inc VNDA Feb 16, 2018 17.10 +1.18   
 VanEck Vectors Biotech ETF BBH Feb 16, 2018 124.75 -0.37   
 VanEck Vectors Generic Drugs ETF GNRX Feb 16, 2018 25.59 +0.59   
 VanEck Vectors Pharmaceutical ETF PPH Feb 16, 2018 60.59 +1.02   
 Vanguard Emerging Markets Gover VWOB Feb 16, 2018 78.41 +0.20   
 Vanguard International Dividend Appreciation ETF VIGI Feb 16, 2018 66.45 +0.36   
 Vanguard International High Dividend Yield ETF VYMI Feb 16, 2018 68.41 +0.03   
 Vanguard Natural Resources Llc VNR Feb 16, 2018 0.20 0.00   
 Vanguard Natural Resources LLC VNRBP Feb 16, 2018 2.00 0.00   
 Vanguard Natural Resources LLC VNRCP Feb 16, 2018 2.00 0.00   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Feb 16, 2018 2.26 0.00   
 Vanguard Short-Term Inflation-P VTIP Feb 16, 2018 48.62 +0.04   
 Vanguard Total International Bo BNDX Feb 16, 2018 54.03 +0.28   
 Vantage Energy Acquisition Corp. VEACU Feb 16, 2018 10.10 +0.80   
 Vantage Energy Acquisition Corp. VEAC Feb 16, 2018 9.77 0.00   
 Vantage Energy Acquisition Corp. VEACW Feb 16, 2018 1.30 0.00   
 Varex Imaging Corporation VREX Feb 16, 2018 37.13 +0.08   
 Varonis Systems, Inc. VRNS Feb 16, 2018 56.30 +8.37   
 Vasco Data Security International VDSI Feb 16, 2018 13.85 -0.36   
 Vascular Biogenics Ltd. VBLT Feb 16, 2018 6.30 +2.44   
 Vascular Solutions VASC Feb 16, 2018 56.00 0.00   
 VBI Vaccines, Inc. VBIV Feb 16, 2018 3.76 +3.01   
 Vca Antech WOOF Feb 16, 2018 92.98 0.00   
 Veeco Instruments Inc VECO Feb 16, 2018 18.90 0.00   
 VEON Ltd. VEON Feb 16, 2018 3.56 0.00   
 Vera Bradley VRA Feb 16, 2018 10.45 0.00   
 Veracyte Inc VCYT Feb 16, 2018 5.70 +1.60   
 Verastem Inc VSTM Feb 16, 2018 3.31 +2.64   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now